Lv11
48 积分 2025-05-07 加入
The Selective Sphingosine 1-Phosphate Receptor Modulator Etrasimod Regulates Lymphocyte Trafficking and Alleviates Experimental Colitis
6小时前
已完结
The discovery and development of the sphingosine 1-phosphate receptor modulator ozanimod in ulcerative colitis
6小时前
求助中
Generation of PT101, a highly selective IL-2 mutein for treatment of autoimmune diseases
23天前
已关闭
Chemerin in immunity
1个月前
已完结
Blockade of IL-18 signaling downregulates homing of effector CD4+ T cells to the gut mucosa and provides protection from experimental IBD
1个月前
已关闭
TYK2 as a Therapeutic Target in the Treatment of Autoimmune and Inflammatory Diseases
1个月前
已完结
TYK2 as a Therapeutic Target in the Treatment of Autoimmune and Inflammatory Diseases
1个月前
已完结
Solution-Phase Kinetics of Ranibizumab Binding VEGF Using Solid-Phase Surface Plasmon Resonance
1个月前
已完结
Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases
2个月前
已完结
GPR35: from enigma to therapeutic target
2个月前
已完结
皖公网安备34019202002308
